Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

Eur Respir J. 2018 Jul 4;52(1):1800934. doi: 10.1183/13993003.00934-2018. Print 2018 Jul.
No abstract available

Publication types

  • Letter
  • Systematic Review

MeSH terms

  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Diarylquinolines / adverse effects
  • Diarylquinolines / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Nitroimidazoles / adverse effects
  • Nitroimidazoles / therapeutic use*
  • Oxazoles / adverse effects
  • Oxazoles / therapeutic use*
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • bedaquiline